• LAST PRICE
    89.7850
  • TODAY'S CHANGE (%)
    Trending Up2.4650 (2.8230%)
  • Bid / Lots
    89.7200/ 6
  • Ask / Lots
    89.8100/ 1
  • Open / Previous Close
    88.6000 / 87.3200
  • Day Range
    Low 88.0300
    High 91.0600
  • 52 Week Range
    Low 50.2000
    High 126.8899
  • Volume
    1,115,887
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 87.32
TimeVolumeLNTH
09:32 ET1292888.85
09:33 ET662088.91
09:35 ET1923489.3695
09:37 ET172688.37
09:39 ET475388.78
09:42 ET428588.38
09:44 ET401188.77
09:46 ET722888.73
09:48 ET320689.6
09:50 ET1895590.2
09:51 ET1525990.2
09:53 ET1475690.16
09:55 ET206890.16
09:57 ET522590.395
10:00 ET1677290.255
10:02 ET285590.38
10:04 ET854490.575
10:06 ET1210191.04
10:08 ET1366190.48
10:09 ET436290.6846
10:11 ET572890.4
10:13 ET450090.47
10:15 ET284590.395
10:18 ET469790.49
10:20 ET435890.665
10:22 ET218590.63
10:24 ET391790.765
10:26 ET2144290.79
10:27 ET124690.735
10:29 ET996990.1
10:31 ET677690.35
10:33 ET1913690.545
10:36 ET655090.57
10:38 ET582490.625
10:40 ET384590.85
10:42 ET730690.6
10:44 ET2129490.51
10:45 ET823090.75
10:47 ET449990.84
10:49 ET1544190.38
10:51 ET578790.325
10:54 ET2150190.07
10:56 ET4651689.75
10:58 ET773390.14
11:00 ET60090.095
11:02 ET781390.23
11:03 ET310090.21
11:05 ET734590.2
11:07 ET445890.19
11:09 ET968990.175
11:12 ET522090.28
11:14 ET329890.245
11:16 ET236990.25
11:18 ET607690.35
11:20 ET285090.275
11:21 ET402390.06
11:23 ET200090.25
11:25 ET350090.2301
11:27 ET469390.09
11:30 ET99590.07
11:32 ET533990.16
11:34 ET214490.28
11:36 ET730090.455
11:38 ET997590.47
11:39 ET595590.51
11:41 ET1191090.605
11:43 ET418090.5
11:45 ET416690.41
11:48 ET200090.44
11:50 ET495090.545
11:52 ET102590.53
11:54 ET607690.61
11:56 ET428590.63
11:57 ET387590.47
11:59 ET274290.49
12:01 ET703990.615
12:03 ET271390.72
12:06 ET524090.82
12:08 ET662790.68
12:10 ET902390.285
12:12 ET70690.29
12:14 ET220490.42
12:15 ET1361089.51
12:17 ET185189.305
12:19 ET392689.46
12:21 ET80089.44
12:24 ET387689.35
12:26 ET274889.34
12:28 ET215989.28
12:30 ET248489.19
12:32 ET641789.24
12:33 ET450489.175
12:35 ET369589.01
12:37 ET286989.1
12:39 ET306088.995
12:42 ET422089.06
12:44 ET518689.26
12:46 ET157889.35
12:48 ET154989.285
12:50 ET393989.27
12:51 ET70589.29
12:53 ET653289.285
12:55 ET120089.29
12:57 ET337889.5
01:00 ET230089.79
01:02 ET304189.8
01:04 ET130589.86
01:06 ET41189.91
01:08 ET565689.95
01:09 ET786289.91
01:11 ET537289.985
01:13 ET103190.07
01:15 ET50089.9975
01:18 ET25089.9927
01:20 ET2325989.94
01:22 ET115189.93
01:24 ET1022989.705
01:26 ET639889.75
01:27 ET88789.76
01:29 ET274289.62
01:31 ET441089.81
01:33 ET59289.785
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLNTH
Lantheus Holdings Inc
6.1B
14.9x
+35.30%
United StatesMMSI
Merit Medical Systems Inc
6.1B
51.4x
+14.05%
United StatesSTVN
Stevanato Group SpA
5.9B
44.6x
---
United StatesINSP
Inspire Medical Systems Inc
5.6B
172.6x
---
United StatesHAE
Haemonetics Corp
4.3B
35.5x
+17.09%
United StatesPRCT
Procept Biorobotics Corp
5.1B
-48.4x
---
As of 2024-11-22

Company Information

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, Ga-DOTA-RM2, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol.

Contact Information

Headquarters
331 Treble Cove RdNORTH BILLERICA, MA, United States 01862
Phone
978-671-8001
Fax
302-636-5454

Executives

Chairman of the Board
Mary Heino
President
Paul Blanchfield
Chief Executive Officer, Director
Brian Markison
Chief Financial Officer, Treasurer
Robert Marshall
Chief People Officer
Jamie Spaeth

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.1B
Revenue (TTM)
$1.5B
Shares Outstanding
69.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.47
EPS
$6.02
Book Value
$11.91
P/E Ratio
14.9x
Price/Sales (TTM)
4.1
Price/Cash Flow (TTM)
12.4x
Operating Margin
32.11%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.